A trial looking at bevacizumab and paclitaxel for HER2 negative breast cancer that has spread or come back (MERiDiAN)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at bevacizumab with paclitaxel for breast cancer that has come back or spread to another part of the body. It was for people whose breast cancer cells have none or a low amount of a protein called HER2 (HER2 negative cancer).

Recruitment start: 27 August 2012

Recruitment end: 26 December 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Miles

Supported by

Experimental Cancer Medicine Centre (ECMC)

Hoffmann LaRoche

NIHR Clinical Research Network: Cancer

Last reviewed: 14 Jun 2018

CRUK internal database number: 10176

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.